融捷健康(300247.SZ):2021年度預盈2310萬元-3000萬元 同比扭虧
格隆匯1月27日丨融捷健康(300247.SZ)披露2021年度業績預吿,預計2021年度實現歸屬於上市公司股東的淨利潤2310.00萬元-3000.00萬元,上年同期為虧損6572.89萬元;預計2021年度實現歸屬於上市公司股東的扣除非經常性損益後的淨利潤500.00萬元-730.00萬元,上年同期為虧損6816.62萬元。
業績扭虧的主要原因系:1、2020年度處置了虧損企業參股公司北京央廣聯合傳媒投資有限公司股權和控股子公司上海瑞宇健身休閒用品有限公司股權;2、2021年度出售了參股公司安徽影聯雲享醫療科技有限公司股權形成了投資收益和公允價值變動收益;3、2021年度公司主營產品遠紅外桑拿房和空氣淨化器銷售收入較上年有所增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.